22nd Century Group (XXII)
(Real Time Quote from BATS)
$0.70 USD
0.00 (-0.64%)
Updated Jun 11, 2024 10:38 AM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
22nd Century Group, Inc [XXII]
Reports for Purchase
Showing records 121 - 134 ( 134 total )
Company: 22nd Century Group, Inc
Industry: Medical - Biomedical and Genetics
Company: 22nd Century Group, Inc
Industry: Medical - Biomedical and Genetics
Company: 22nd Century Group, Inc
Industry: Medical - Biomedical and Genetics
Company: 22nd Century Group, Inc
Industry: Medical - Biomedical and Genetics
Company: 22nd Century Group, Inc
Industry: Medical - Biomedical and Genetics
Company: 22nd Century Group, Inc
Industry: Medical - Biomedical and Genetics
Company: 22nd Century Group, Inc
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: 22nd Century Group, Inc
Industry: Medical - Biomedical and Genetics
Company: 22nd Century Group, Inc
Industry: Medical - Biomedical and Genetics
Company: 22nd Century Group, Inc
Industry: Medical - Biomedical and Genetics
MONTHLY PORTFOLIO UPDATE
Provider: RODMAN & RENSHAW, CO.
Company: 22nd Century Group, Inc
Industry: Unclassified
Company: 22nd Century Group, Inc
Industry: Unclassified
Company: 22nd Century Group, Inc
Industry: Unclassified
We are initiating coverage with a Market Outperform/Speculative Risk rating and a 12-month price target of $5/share.
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E
Company: 22nd Century Group, Inc
Industry: Unclassified
We are initiating coverage with a Market Outperform/Speculative Risk rating and a 12-month price target of $5/share.
Provider: RODMAN & RENSHAW, CO.
Analyst: PIROS E